Evidence map›Paper›PMID 38448507›Full record

ReviewNature chemistry2024

Nanopore DNA sequencing technologies and their applications towards single-molecule proteomics.

Adam Dorey, Stefan Howorka

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systematic Review: Long-Read Sequencing in Algal Studies.International journal of molecular sciences · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. De novo design of semisynthetic conduction pores.Nature structural & molecular biology · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Biosensing With Nanofluidics.Exploration (Beijing, China) · 2026
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Adam DoreyDepartment of Chemistry & Institute of Structural Molecular Biology, University College London, London, UK. a.dorey@ucl.ac.uk.ORCID 0000-0003-1771-9436
Stefan HoworkaDepartment of Chemistry & Institute of Structural Molecular Biology, University College London, London, UK. s.howorka@ucl.ac.uk.ORCID 0000-0002-6527-2846

Funding

Human Frontier Science Program (HFSP) RGP0047/2020RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/N009282/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/V02874X/1
6 · The paper itself

Abstract

Sequencing of nucleic acids with nanopores has emerged as a powerful tool offering rapid readout, high accuracy, low cost and portability. This label-free method for sequencing at the single-molecule level is an achievement on its own. However, nanopores also show promise for the technologically even more challenging sequencing of polypeptides, something that could considerably benefit biological discovery, clinical diagnostics and homeland security, as current techniques lack portability and speed. Here we survey the biochemical innovations underpinning commercial and academic nanopore DNA/RNA sequencing techniques, and explore how these advances can fuel developments in future protein sequencing with nanopores.

Indexed as

NanoporesDNAProteomicsSequence Analysis, DNATechnologyDNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.